1) oridonin derivative
冬凌草甲素衍生物
1.
In order to study the structure-activity relationship of oridonin derivatives, the target compound oridonin-6-O-β-D-glucopyranoside was synthesized from oridonin and tetra-O-benzoyl-α-D-glucopyranosyl bromide via protection, Koenigs-Knorr reaction and deprotection in the total yield of 23.
0%的总收率,合成了冬凌草甲素-6-O-β-D-葡萄糖苷,并得到一系列冬凌草甲素衍生物,它们的结构经IR,HNMR,MS和元素分析确证。
2) Oridonin
冬凌草甲素
1.
Orthogonal Experimental Research on Decoction Technology of Oridonin;
冬凌草甲素提取工艺的正交实验研究
2.
Determination of Oridonin in Rabdosia Rubescens tea by Reversed Phase High Performance Liquid Chromatography;
反相高效液相色谱法测定冬凌草茶中的冬凌草甲素
3.
New method for preparing oridonin by supercritical CO_2 fluid extraction and column chromatography;
超临界CO_2萃取-柱色谱分离联用制备冬凌草甲素新工艺的研究
3) rubescensine A
冬凌草甲素
1.
Study on the quantum chemical calculations is performed by means of MNDO method on VAX8350 computer for rubescensine A and its acetylate derivative.
本文用ＭＮＤＯ方法在ＶＡＸ８３５０计算机上对冬凌草甲素及其乙酰衍生物进行了量子化学计算研究。
2.
Objective: To investigate the mechanism of GBC-SD(gallbladder cell-Shandong) apoptosis induced by Rubescensine A.
目的:探讨冬凌草甲素(RuA)对人胆囊癌细胞株(GBC-SD)诱导凋亡的机制。
3.
One of its main components, Rubescensine A, was extracted and expected to become a new Class I drug in Wuhan Botanical Garden, the Chinese Academy of Sciences.
中国科学院武汉植物园从冬凌草药材中提取出冬凌草甲素，制成了抗癌一类新药RAC。
4) rubescensine A and B
冬凌草甲素、乙素
1.
This paper reviews the latest research status of rubescensine A and B by collecting and analyzing literature from many countries,including extraction,separation,pharmacological action,pharmaceutical preparation and pharmacokinetic.
冬凌草甲素、乙素具有多种药理作用,尤其是抗癌活性。
5) oridonin glucopyranoside
冬凌草甲素糖苷
6) Xindonin A
信阳冬凌草甲素
1.
Study on the Inclusions of Xindonin A-p-cyclodextrin and Xindonin B-β-cyclodextrin;
信阳冬凌草甲素和乙素β-环糊精包合物的研究
补充资料：大凌风草
形态特征 禾本科凌风草属多年生草本植物，秆高45-60厘米。上部叶舌长1毫米或更长，叶片宽5毫米左右。圆锥花序开展，长8-10厘米，小穗宽卵形，紫色，长4-6毫米，含4-8枚水平开展的小花。
生境分布 生于冷杉林草地。产于西藏。欧洲、印度也有。
生境分布 生于冷杉林草地。产于西藏。欧洲、印度也有。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条